[{"NetIncomeLoss_1_Q2_USD":-43894000.0,"GeneralAndAdministrativeExpense_2_Q2_USD":22832000.0,"GeneralAndAdministrativeExpense_1_Q2_USD":13353000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_2_Q2_shares":30190352.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q2_shares":30274749.0,"CommitmentsAndContingencies_0_Q2_USD":null,"AccruedLiabilitiesCurrent_0_Q2_USD":20775000.0,"DerivativeLiabilitiesCurrent_0_Q2_USD":2202000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q2_USD":-13000.0,"NetCashProvidedByUsedInInvestingActivities_2_Q2_USD":-57239000.0,"PaymentsToAcquireInvestments_2_Q2_USD":129336000.0,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_2_Q2_USD":-6000.0,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_1_Q2_USD":3000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q2_USD":925000.0,"AssetsCurrent_0_Q2_USD":228366000.0,"OperatingLeaseExpense_2_Q2_USD":300000.0,"OperatingLeaseExpense_1_Q2_USD":200000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_2_Q2_shares":7138234.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q2_USD":295000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q2_USD":916000.0,"CommonStockSharesIssued_0_Q2_shares":30506433.0,"Assets_0_Q2_USD":247668000.0,"ShareBasedCompensation_2_Q2_USD":10108000.0,"OperatingLeaseRightOfUseAsset_0_Q2_USD":1758000.0,"CommonStockCapitalSharesReservedForFutureIssuance_0_Q2_shares":9484950.0,"PreferredStockParOrStatedValuePerShare_0_Q2_USD":0.0001,"PreferredStockSharesOutstanding_0_Q2_shares":0.0,"OperatingLeaseLiability_0_Q2_USD":2942000.0,"ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_2_Q2_USD":1018000.0,"Liabilities_0_Q2_USD":151931000.0,"FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationIssues_1_Q2_USD":1272000.0,"ShortTermInvestments_0_Q2_USD":131913000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q2_USD":437000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q2_USD":3398000.0,"ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities_2_Q2_USD":70100000.0,"OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_2_Q2_USD":-90000.0,"OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent_1_Q2_USD":-16000.0,"OtherNonoperatingIncomeExpense_2_Q2_USD":-530000.0,"OtherNonoperatingIncomeExpense_1_Q2_USD":-514000.0,"IncomeTaxExpenseBenefit_2_Q2_USD":16000.0,"IncomeTaxExpenseBenefit_1_Q2_USD":11000.0,"CommonStockValue_0_Q2_USD":3000.0,"CommonStockParOrStatedValuePerShare_0_Q2_USD":0.0001,"AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_0_Q2_USD":14990000.0,"DepreciationDepletionAndAmortization_2_Q2_USD":169000.0,"ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_2_Q2_USD":73182000.0,"ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost_1_Q2_USD":35048000.0,"NetCashProvidedByUsedInFinancingActivities_2_Q2_USD":72506000.0,"AvailableForSaleSecuritiesDebtMaturitiesNextRollingTwelveMonthsFairValue_0_Q2_USD":131913000.0,"ShareBasedGoodsAndNonemployeeServicesTransactionModificationOfTermsIncrementalCompensationCost_2_Q2_USD":300000.0,"ComprehensiveIncomeNetOfTax_2_Q2_USD":-94522000.0,"ComprehensiveIncomeNetOfTax_1_Q2_USD":-43907000.0,"OtherAssetsNoncurrent_0_Q2_USD":1427000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q2_USD":91938000.0,"OperatingLeaseLiabilityNoncurrent_0_Q2_USD":2271000.0,"AdditionalPaidInCapitalCommonStock_0_Q2_USD":363344000.0,"DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger_0_Q2_USD":0.0,"FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisUnobservableInputsReconciliationIssues_2_Q2_USD":938000.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q2_USD":456000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_2_Q2_USD":-103000.0,"CommonStockSharesOutstanding_0_Q2_shares":30317173.0,"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPurchasesSalesIssuancesSettlements_2_Q2_USD":-938000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_2_Q2_USD":-94410000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q2_USD":-43883000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q2_USD":4823000.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":-65409000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q2_USD":888000.0,"LiabilitiesCurrent_0_Q2_USD":29028000.0,"PaymentsForProceedsFromInvestments_1_Q2_USD":65000000.0,"AccountsPayableCurrent_0_Q2_USD":5380000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q2_USD":4515000.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_2_Q2_USD":-6000.0,"CashAndCashEquivalentsFairValueDisclosure_0_Q2_USD":84081000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q2_pure":0.08,"IncreaseDecreaseInOtherOperatingAssets_2_Q2_USD":162000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_0_Q2_USD":91938000.0,"StockIssuedDuringPeriodValueEmployeeStockPurchasePlan_1_Q2_USD":643000.0,"NumberOfOperatingSegments_2_Q2_Segment":1.0,"OperatingLeasePayments_2_Q2_USD":426000.0,"HeldToMaturitySecuritiesFairValue_0_Q2_USD":146903000.0,"AvailableForSaleSecuritiesGrossRealizedGainLossNet_2_Q2_USD":0.0,"AvailableForSaleSecuritiesGrossRealizedGainLossNet_1_Q2_USD":0.0,"PreferredStockSharesIssued_0_Q2_shares":0.0,"PropertyPlantAndEquipmentNet_0_Q2_USD":1127000.0,"NetIncomeLoss_2_Q2_USD":-94426000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_2_Q2_USD":-50148000.0,"RetainedEarningsAccumulatedDeficit_0_Q2_USD":-267597000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_2_Q2_USD":22000.0,"LongTermInvestments_0_Q2_USD":14990000.0,"CommonStockSharesAuthorized_0_Q2_shares":200000000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_2_Q2_USD":11000000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q2_USD":11000000.0,"OperatingIncomeLoss_2_Q2_USD":-85014000.0,"OperatingIncomeLoss_1_Q2_USD":-37401000.0,"OtherThanTemporaryImpairmentLossDebtSecuritiesAvailableForSale_2_Q2_USD":0.0,"AvailableForSaleSecuritiesDebtSecuritiesCurrent_0_Q2_USD":131913000.0,"ProceedsFromIssuanceInitialPublicOffering_2_Q2_USD":6914000.0,"InvestmentIncomeInterest_2_Q2_USD":229000.0,"InvestmentIncomeInterest_1_Q2_USD":80000.0,"PreferredStockValue_0_Q2_USD":null,"LiabilitiesAndStockholdersEquity_0_Q2_USD":247668000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q2_USD":232000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q2_USD":4530000.0,"AllocatedShareBasedCompensationExpense_2_Q2_USD":10108000.0,"AllocatedShareBasedCompensationExpense_1_Q2_USD":4823000.0,"OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent_1_Q2_USD":-13000.0,"OperatingLeaseLiabilityCurrent_0_Q2_USD":671000.0,"OperatingExpenses_2_Q2_USD":96014000.0,"OperatingExpenses_1_Q2_USD":48401000.0,"EarningsPerShareBasicAndDiluted_2_Q2_USD":-3.13,"EarningsPerShareBasicAndDiluted_1_Q2_USD":-1.45,"ProfitLoss_2_Q2_USD":-94426000.0,"OtherLiabilitiesNoncurrent_0_Q2_USD":22000.0,"StockholdersEquity_0_Q2_USD":95737000.0,"PaymentsToAcquirePropertyPlantAndEquipment_2_Q2_USD":3000.0,"PreferredStockSharesAuthorized_0_Q2_shares":10000000.0,"AccruedProfessionalFeesCurrent_0_Q2_USD":3459000.0,"Ticker":"MIRM","CIK":"1759425","name":"MIRUM PHARMACEUTICALS, INC.","OfficialName":"Mirum Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20210630","fy":"2021.0","fp":"Q2","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"824673616.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20210805"}]